(Q34956163)

English

A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance

scientific article

Statements

A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance (English)
1 January 2002

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit